Physician Notices and Updates
Register today for April 15 webinar: Stopping TB Before it Starts: TBI (Latent TB) Screening and Treatment in Primary Care
Mar 31, 2026Register now for the upcoming Mainpro+ accredited webinar, Public Health Updates for Halton Physicians: Focus on Tuberculosis Infection (Latent TB). The session “Stopping TB Before It Starts: TBI (Latent TB) Screening & Treatment for Primary Care” is on
Blog Posts
Register now for the upcoming Mainpro+ accredited webinar, Public Health Updates for Halton Physicians: Focus on Tuberculosis Infection (Latent TB). The session “Stopping TB Before It Starts: TBI (Latent TB) Screening & Treatment for Primary Care” is on
The Ministry of Health has extended the RSV prevention program for infants and high-risk children into .
Effective April 1, 2026, PHO will no longer supply most specimen collection materials. Impacted healthcare providers should begin sourcing supplies from alternate vendors.
COVaxON, the provincial program used for COVID-19 immunization records and inventory management, will be decommissioned on
The Ministry of Health has notified local public health units that the ongoing national shortage of Benzathine Penicillin G (Bicillin® L-A) 1,200,000 IU/2mL, indicated as the first line treatment for syphilis, is now expected to continue until .
Blog Posts
Register now for the upcoming Mainpro+ accredited webinar, Public Health Updates for Halton Physicians: Focus on Tuberculosis Infection (Latent TB). The session “Stopping TB Before It Starts: TBI (Latent TB) Screening & Treatment for Primary Care” is on
The Ministry of Health has extended the RSV prevention program for infants and high-risk children into .
Effective April 1, 2026, PHO will no longer supply most specimen collection materials. Impacted healthcare providers should begin sourcing supplies from alternate vendors.
COVaxON, the provincial program used for COVID-19 immunization records and inventory management, will be decommissioned on
The Ministry of Health has notified local public health units that the ongoing national shortage of Benzathine Penicillin G (Bicillin® L-A) 1,200,000 IU/2mL, indicated as the first line treatment for syphilis, is now expected to continue until .